Acetyl-l-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acetyl-l-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study

Published:2016-11 Issue:6 Volume:39 Page:277-280
ISSN:1537-162X
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:Clin Neuropharm

Author:

Bruno Antonio,Pandolfo Gianluca,Crucitti Manuela,Lorusso Simona,Zoccali Rocco Antonio,Muscatello Maria Rosaria Anna

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference24 articles.

1. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT);Arch Gen Psychiatry,2003

2. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis;Lancet,2013

3. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials;Am J Psychiatry,2001

4. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine;Expert Opin Pharmacother,2014

5. Pharmacotherapy of treatment-resistant schizophrenia: a clinical perspective;Evid Based Ment Health,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple acyl‐Coa dehydrogenase deficiency: an underdiagnosed disorder in adults;Internal Medicine Journal;2024-08-12

2. Metabolomics, Lipidomics, and Antipsychotics: A Systematic Review;Biomedicines;2023-12-13

3. Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetically Targeted Therapeutic Approaches;Neurochemical Journal;2023-12

4. Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetic-Targeted Therapeutic Approaches;Нейрохимия;2023-10-01

5. Alterations in Plasma Lipidomic Profiles in Adult Patients with Schizophrenia and Major Depressive Disorder;Medicina;2022-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3